Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 18


The expression and prognostic significance of bcl-2-associated transcription factor 1 in rectal cancer following neoadjuvant therapy.

Brown GT, Cash B, Alnabulsi A, Samuel LM, Murray GI.

Histopathology. 2015 Jul 16. doi: 10.1111/his.12780. [Epub ahead of print]


Increased lymph node yield in colorectal cancer is not necessarily associated with a greater number of lymph node positive cancers.

O'Shea A, Aly O, Parnaby CN, Loudon MA, Samuel LM, Murray GI.

PLoS One. 2014 Aug 13;9(8):e104991. doi: 10.1371/journal.pone.0104991. eCollection 2014.


Common variation near CDKN1A, POLD3 and SHROOM2 influences colorectal cancer risk.

Dunlop MG, Dobbins SE, Farrington SM, Jones AM, Palles C, Whiffin N, Tenesa A, Spain S, Broderick P, Ooi LY, Domingo E, Smillie C, Henrion M, Frampton M, Martin L, Grimes G, Gorman M, Semple C, Ma YP, Barclay E, Prendergast J, Cazier JB, Olver B, Penegar S, Lubbe S, Chander I, Carvajal-Carmona LG, Ballereau S, Lloyd A, Vijayakrishnan J, Zgaga L, Rudan I, Theodoratou E; Colorectal Tumour Gene Identification (CORGI) Consortium, Starr JM, Deary I, Kirac I, Kovacević D, Aaltonen LA, Renkonen-Sinisalo L, Mecklin JP, Matsuda K, Nakamura Y, Okada Y, Gallinger S, Duggan DJ, Conti D, Newcomb P, Hopper J, Jenkins MA, Schumacher F, Casey G, Easton D, Shah M, Pharoah P, Lindblom A, Liu T; Swedish Low-Risk Colorectal Cancer Study Group, Smith CG, West H, Cheadle JP; COIN Collaborative Group, Midgley R, Kerr DJ, Campbell H, Tomlinson IP, Houlston RS.

Nat Genet. 2012 May 27;44(7):770-6. doi: 10.1038/ng.2293.


Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial.

Adams RA, Meade AM, Seymour MT, Wilson RH, Madi A, Fisher D, Kenny SL, Kay E, Hodgkinson E, Pope M, Rogers P, Wasan H, Falk S, Gollins S, Hickish T, Bessell EM, Propper D, Kennedy MJ, Kaplan R, Maughan TS; MRC COIN Trial Investigators.

Lancet Oncol. 2011 Jul;12(7):642-53. doi: 10.1016/S1470-2045(11)70102-4. Epub 2011 Jun 5.


Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial.

Maughan TS, Adams RA, Smith CG, Meade AM, Seymour MT, Wilson RH, Idziaszczyk S, Harris R, Fisher D, Kenny SL, Kay E, Mitchell JK, Madi A, Jasani B, James MD, Bridgewater J, Kennedy MJ, Claes B, Lambrechts D, Kaplan R, Cheadle JP; MRC COIN Trial Investigators.

Lancet. 2011 Jun 18;377(9783):2103-14. doi: 10.1016/S0140-6736(11)60613-2. Epub 2011 Jun 5.


Toward shared care for people with cancer: developing the model with patients and GPs.

Hall SJ, Samuel LM, Murchie P.

Fam Pract. 2011 Oct;28(5):554-64. doi: 10.1093/fampra/cmr012. Epub 2011 Apr 5.


APRIL is a novel clinical chemo-resistance biomarker in colorectal adenocarcinoma identified by gene expression profiling.

Petty RD, Samuel LM, Murray GI, MacDonald G, O'Kelly T, Loudon M, Binnie N, Aly E, McKinlay A, Wang W, Gilbert F, Semple S, Collie-Duguid ES.

BMC Cancer. 2009 Dec 11;9:434. doi: 10.1186/1471-2407-9-434.


The spectrum of 5-fluorouracil cardiotoxicity.

Dalzell JR, Samuel LM.

Anticancer Drugs. 2009 Jan;20(1):79-80. Review.


A multi-centre dose-escalation and pharmacokinetic study of diflomotecan in patients with advanced malignancy.

Graham JS, Falk S, Samuel LM, Cendros JM, Evans TR.

Cancer Chemother Pharmacol. 2009 Apr;63(5):945-52. doi: 10.1007/s00280-008-0795-6. Epub 2008 Jul 25.


A phase II study of mitomycin C, cisplatin and protracted infusional 5-fluorouracil in advanced pancreatic carcinoma: efficacy and low toxicity.

Petty RD, Nicolson MC, Skaria S, Sinclair TS, Samuel LM, Koruth M; Aberdeen Pancreatic Cancer Focus Group.

Ann Oncol. 2003 Jul;14(7):1100-5.


Extramedullary plasmacytoma of the eyelid.

Ahamed E, Samuel LM, Tighe JE.

Br J Ophthalmol. 2003 Feb;87(2):244-5. Review. No abstract available.


Primary non-Hodgkins lymphoma of muscle.

Samuel LM, White J, Lessells AM, Roddie H, Matheson LM.

Clin Oncol (R Coll Radiol). 1999;11(1):49-51.


Pleurocutaneous fistula as a complication of radiation treatment in locally advanced breast cancer.

Samuel LM, Kunkler IH, Dixon JM, Walker WS.

J R Coll Surg Edinb. 1997 Apr;42(2):138-9.


A rapidly enlarging keratinised 'skull-cap'.

Samuel LM, Matheson LM.

Postgrad Med J. 1997 Feb;73(856):111-3. No abstract available.


Massive cutaneous large cell T-cell non-Hodgkin's lymphoma of the pinna.

Samuel LM, Matheson LM, MacDougall G, Morrison A.

Clin Oncol (R Coll Radiol). 1995;7(3):196-7.


Phase II trial of procarbazine, vincristine and lomustine (POC) chemotherapy in metastatic cutaneous malignant melanoma.

Samuel LM, Harvey VJ, Mitchell PL, Thompson PI, Mak D, Melville P, Evans BD.

Eur J Cancer. 1994;30A(14):2054-6.


Amiodarone and hair loss.

Samuel LM, Davie M, Starkey IR.

Postgrad Med J. 1992 Sep;68(803):771. No abstract available.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk